Literature DB >> 1878752

Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle.

A D Wickenden1, S Grimwood, T L Grant, M H Todd.   

Abstract

1 The actions of the potassium channel openers, cromakalim and minoxidil sulphate, were compared in a range of isolated blood vessel preparations. 2 Cromakalim and minoxidil sulphate inhibited spontaneous mechanical activity of the guinea-pig portal vein and relaxed the noradrenaline precontracted rat aorta with similar potency. In contrast, minoxidil sulphate was less potent than cromakalim in inhibiting spontaneous activity in the rat portal vein and was essentially inactive in the noradrenaline precontracted rat mesenteric artery and rabbit aorta. 3 Minoxidil sulphate did not antagonize the effects of cromakalim in the rabbit aorta indicating it was not acting as a partial 'agonist'. 4 Charybdotoxin, noxiustoxin and rubidium failed to discriminate between cromakalim and minoxidil sulphate indicating that the apparently selective effects of minoxidil sulphate were not mediated by either Ca(2+)-activated potassium channels, delayed rectifiers or rubidium impermeable potassium channels. 5 Glibenclamide antagonized the effects of cromakalim in an apparently competitive manner whereas the effects of minoxidil sulphate were antagonized in a non-competitive manner. The involvement of subtypes of ATP-sensitive potassium channels is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878752      PMCID: PMC1908107          DOI: 10.1111/j.1476-5381.1991.tb12315.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  A Ca2+-activated K+ channel from rabbit aorta: modulation by cromakalim.

Authors:  C H Gelband; N J Lodge; C Van Breemen
Journal:  Eur J Pharmacol       Date:  1989-08-22       Impact factor: 4.432

2.  Cromakalim, RP49356, pinacidil and minoxidil sulphate in the rat uterus and their antagonism by glibenclamide. Smooth Muscle Research Group.

Authors:  I Piper; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.

Authors:  R J Winquist; L A Heaney; A A Wallace; E P Baskin; R B Stein; M L Garcia; G J Kaczorowski
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

4.  Selective blockage of voltage-dependent K+ channels by a novel scorpion toxin.

Authors:  E Carbone; E Wanke; G Prestipino; L D Possani; A Maelicke
Journal:  Nature       Date:  1982-03-04       Impact factor: 49.962

5.  Properties of the cromakalim-induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein.

Authors:  D J Beech; T B Bolton
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

6.  The effect of cromakalim on the smooth muscle of the guinea-pig urinary bladder.

Authors:  C D Foster; K Fujii; J Kingdon; A F Brading
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

7.  Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.

Authors:  R E Buckingham; T C Hamilton; D R Howlett; S Mootoo; C Wilson
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

8.  Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein.

Authors:  T C Hamilton; S W Weir; A H Weston
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

9.  Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine.

Authors:  R F Kauffman; K W Schenck; B G Conery; M L Cohen
Journal:  J Cardiovasc Pharmacol       Date:  1986 Nov-Dec       Impact factor: 3.105

10.  Electrophysiological mechanisms of minoxidil sulfate-induced vasodilation of rabbit portal vein.

Authors:  N Leblanc; D W Wilde; K D Keef; J R Hume
Journal:  Circ Res       Date:  1989-10       Impact factor: 17.367

View more
  8 in total

Review 1.  Electrophysiologic effects of potassium channel openers.

Authors:  W Haverkamp; M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 2.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

3.  Levcromakalim may induce a voltage-independent K-current in rat portal veins by modifying the gating properties of the delayed rectifier.

Authors:  G Edwards; T Ibbotson; A H Weston
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.

Authors:  I Nakae; L Quan; K Hashimoto; Y Sugimoto; T Tsutamoto; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

5.  Levcromakalim-induced modulation of membrane potassium currents, intracellular calcium and mechanical activity in rat mesenteric artery.

Authors:  D N Criddle; I A Greenwood; A H Weston
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

6.  Potassium channel modulation in rat portal vein by ATP depletion: a comparison with the effects of levcromakalim (BRL 38227).

Authors:  T Noack; G Edwards; P Deitmer; A H Weston
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  Characterization of potassium currents modulated by BRL 38227 in rat portal vein.

Authors:  T Noack; P Deitmer; G Edwards; A H Weston
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

8.  KATP Channel Openers Inhibit Lymphatic Contractions and Lymph Flow as a Possible Mechanism of Peripheral Edema.

Authors:  Brittney R Garner; Amanda J Stolarz; Daniel Stuckey; Mustafa Sarimollaoglu; Yunmeng Liu; Philip T Palade; Nancy J Rusch; Shengyu Mu
Journal:  J Pharmacol Exp Ther       Date:  2020-10-25       Impact factor: 4.030

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.